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Introduction
============

Precursor cells that generate the various differentiated cell types of the central nervous system (CNS) are generally located in defined areas of the developing embryo, which frequently correspond to the ventricular zones of the developing nervous system. During a large part of the development of the embryo, neural progenitors proliferate to renew the precursor pool and, in parallel, give rise to postmitotic cells that move out of the progenitor areas ([@bib39]). The balance between the generation of precursor and postmitotic cells shifts during development but has to be tightly controlled to guarantee the formation of the appropriate neuronal cell numbers and the size of the tissue domains. Nervous tissue in the vertebrate embryo arises through complex processes of neural induction of the ectoderm, the delineation of neurogenesis-competent domains within the neural plate, and differentiation of neural precursors within these regions ([@bib19]; [@bib4]; [@bib17]). Simultaneously, the expansion of each neuronal compartment takes place until its definitive size and form are reached. At this point in time, the neurons undergo terminal differentiation, thereby acquiring the characteristics necessary for participation in nervous signal propagation while simultaneously losing their capacity for further proliferation.

As the mechanisms controlling the spatio-temporal timing of the sequence of proliferation and differentiation of neuronal-committed cells are still only partly understood, we performed a differential display of mRNAs designed to isolate genes that are differently expressed during neuronal differentiation as well as genes responsible for the proliferation of the stem cell compartment in vivo.

Results
=======

Identification of *d-Asb11* as a differentiation down-regulated gene
--------------------------------------------------------------------

We used a differential display screen to discover genes that are involved in control of neural stem cell compartment proliferation. To this end, zebrafish embryos were either left untreated or were pulse treated with 0.5 μM all-trans retinoic acid (RA) between 50 and 60% epiboly when neural induction and patterning are initiated. Subsequently, mRNA was isolated from wild-type and treated embryos at 90% epiboly, which, after conversion into cDNA, was used for a differential display using the transcripts from the untreated embryos as driver cDNA and the transcripts from the treated embryos as tester cDNA. The resulting differential fragments were tested using whole-mount in situ hybridization at different developmental stages. One fragment was singled out for detailed characterization based on its restricted spatio-temporal expression pattern during late gastrulation and early somitogenesis. Obtaining a full-length sequence of the down-regulated fragment revealed that the gene was most homologous to mammalian ASB11 (ankyrin repeat and suppressor of cytokine signaling \[SOCS\] box--containing protein 11), thus identifying this gene as *d-asb11* (sequence is deposited at the National Center for Biotechnology Information under GenBank/EMBL/DDBJ accession no. [AJ510191](AJ510191); [Fig. 1 A](#fig1){ref-type="fig"}, supplemental material, and Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200601081/DC1>).

![**Discovery, characterization, and expression of *d-asb11*.** (A) Amino acid sequence of the d-Asb11 protein. The detection of a down-regulated 0.34-kb fragment in RA-treated embryos in the differential display screen. (B) Expression of *d-asb11* in zebrafish embryos. (top) At 50% epiboly (5 hpf), *d-asb11* transcripts are present throughout the blastoderm (animal pole up). (bottom) At 95% epiboly (9.5 hpf), *d-asb11* transcripts are at a high level localized to the polster (p; lateral view, anterior up). (C) At the tailbud stage (10 hpf), the expression is strongest in the polster and along the margins of the neural plate. Weaker expression is present in two stripes extending toward the midline (asterisks) and in paraxial domains (a compilation of images; dorsal view anterior to the top). (D) Double label in situ hybridization at approximately three somites; *d-asb11* is in blue, and *deltaA* is in red. The expression of *deltaA* in longitudinal proneuronal domains is complemented by the expression of *d-asb11* in the neural plate margins. (E) Asterisks mark regions of the prospective mid/hindbrain boundary. (left) Expression pattern of *d-asb11* in zebrafish embryos at 90% epiboly. (right) Embryos treated with RA in which *d-asb11* expression is absent in the anterior and diminished in the posterior part of the embryo (anterior to the left). The asterisks represent similar positions of the embryo. Bars, 100 μm.](jcb1740581f01){#fig1}

Expression of d-Asb11 suggests a role in the developing nervous system
----------------------------------------------------------------------

ASB family members contain a relatively divergent N-terminal domain followed by a varying number of ankyrin repeats and a C-terminal SOCS box acting as a part of a ubiquitin ligase complex ([@bib26]; [@bib46]; [@bib10]; [@bib21]) and are expressed in members throughout the chordate phylum ([@bib25]; [@bib29]; [@bib16]). *d-asb11* was not maternally expressed because the transcripts were not detected by in situ hybridization or Northern blotting in 2.5 h postfertilization (hpf) embryos (unpublished data). The expression of *d-asb11* was by in situ hybridization first detected at 4 hpf and was ubiquitous throughout the blastoderm ([Fig. 1 B](#fig1){ref-type="fig"}), and such uniform expression was maintained until late gastrula, when *d-asb11* transcripts were restricted to the polster ([Fig. 1 B](#fig1){ref-type="fig"}). At the tailbud, neuroectodermal expression extends as two stripes along the margins of the neural plate ([Fig. 1 C](#fig1){ref-type="fig"}), most likely overlapping with the posterior lateral neural plate expression of *notch 1b* and the lateral neural plate expression of *notch 3* (Figs. 2 and 3 in [@bib45]) and being complementary to proneural domains expressing *deltaA* ([Fig. 1 D](#fig1){ref-type="fig"}). At the level of the prospective mid/hindbrain boundary, two bilateral domains of expression are detected ([Fig. 1, C and E](#fig1){ref-type="fig"}). The expression is transient, as this pattern is maintained until 12 somites. From 12 somites to at least 3 d after fertilization, there was no expression detectable by in situ hybridization, although low levels of mRNA were still detected in 24 hpf embryos by Northern blotting (unpublished data). In RA-treated embryos, the expression of *d-asb11* is absent in the anterior half and down-regulated in the posterior half of the embryo, which is consistent with its isolation as a down-regulated fragment from the differential display screen ([Fig. 1 E](#fig1){ref-type="fig"}). Thus, the expression of *d-asb11* may indicate its possible function in the spatio-temporal timing of proliferation and differentiation in the developing nervous system.

Knockdown of d-Asb11 causes premature neuronal commitment
---------------------------------------------------------

Direct in vivo evidence for a role of *d-asb11* in zebrafish development was obtained from d-Asb11 knockdown by the injection of morpholinos (MOs) designed to inactivate *d-asb11* (d-Asb11--MO; [@bib33]). We generated an antibody against d-Asb11, tested it on transfected cells, and confirmed it by Western blotting of embryo extracts upon MO injection of zygotes, which resulted in embryos devoid of d-Asb11 protein (supplemental material and Fig. S2 C, available at <http://www.jcb.org/cgi/content/full/jcb.200601081/DC1>). We assessed the effects of two different *d-asb11* ATG MOs on development, and both gave similar phenotypes (see Materials and methods section MOs). At 3 d after fertilization, morphants were typically smaller with a shortened trunk, sometimes accompanied by a downward-directed curly tail and a hyperpericardium ([Fig. 2 A](#fig2){ref-type="fig"}). Rescue experiments were performed in which d-Asb11 knockdown by MO that targets sequences upstream of ATG was rescued with the overexpression of myc tag (*MT*)*--d-asb11* mRNA lacking these sequences. Based on the morphology, the overexpression of *MT--d-asb11* (MO+) rescued 50% of the *d-asb11* phenotype (MO), as shown by a decrease in phenotype from 50 to 25% ([Fig. 2 A](#fig2){ref-type="fig"}).

![**Modulation of the neural precursor compartment upon knockdown of d-Asb11.** (A) Phenotypes of a wild-type (WT), *d-Asb11* morpholino (MO)-injected, and inverted MO (INV)-injected embryo at 3 d after fertilization. (right) Rescue of *d-asb11* MO-injected embryos with *MT--d-asb11* mRNA (see Materials and methods). NI, not injected; MO, MO-injected embryos; MO+, MO and *MT--d-asb11*--injected embryos. The percentage of altered phenotype was scored for the different groups, and the data shown are representative of four independent experiments. (B) The level and surface of *ngn1* expression in the neural tube of 20 hpf embryos were enhanced in morphants (MO) as compared with the control (embryos injected with inverted MO), and quantification of *ngn1* induction shows its significant increase in the morphants (*n* = 5). (C and E) Increase in *ngn1* (C) and *huC* (E) mRNA-expressing cells in the *d-asb11* morphant. Left, control embryos; middle, morphant at approximately three somites; right, magnification of wild-type and MO regional expression of *ngn1* (C) and *huC* (E). (far right) Quantification of the amount of staining to calculate the amount of stained cells (C, *n* = 5; E, *n* = 6). (A--C) The asterisks mark significant differences using a chi-squared test (P \< 0.05). Error bars represent SEM. (D) Increase in *islet1* primary neurons in the morphants at the approximately five-somite stage (right) as compared with embryos injected with inverted MO (for photography improvement, polster was removed from the specimens). Bar (A), 200 μm; (B) 20 μm; (C--E) 100 μm; (C and E, right) 20 μm.](jcb1740581f02){#fig2}

Next, d-Asb11 knockdown experiments were performed to determine changes in the expression of the proneural basic helix loop helix gene *neurogenin1* (*ngn1*) that actively promotes neuronal differentiation, inhibits gliogenesis, and is also expressed in still-dividing neuronal precursors ([@bib6]; [@bib31]). Strikingly, d-Asb11 knockdown led to the expansion of *ngn1* that was first observed at the three-somite stage, when in the morphants, *ngn1* was expressed at a higher level and more contiguously in an otherwise unaffected pattern ([Fig. 2 C](#fig2){ref-type="fig"}). In the neural tube of *d-asb11* morphants, lateral and dorsal expression domains of *ngn1* were substantially expanded, as assessed by image quantification of the *ngn1*-positive surface in transversal sections of representative embryos ([Fig. 2 B](#fig2){ref-type="fig"}). Furthermore, strong ectopic *ngn1* expression appeared at the center of the neural tube in the proliferative zone ([Fig. 2 B](#fig2){ref-type="fig"}). These data show that knockdown of d-Asb11 results in a premature commitment to the neuronal cell lineage.

d-Asb11 knockdown leads to premature postmitotic neuronal differentiation and reduced compartment size
------------------------------------------------------------------------------------------------------

Next, we investigated whether the inhibition of *d-asb11* translation affects the generation of terminally differentiated neurons by analyzing the expression of *huC*, a marker for postmitotic neurons. Again at the three-somite stage, *huC* expression was increased in the morphants ([Fig. 2 E](#fig2){ref-type="fig"}) as compared with embryos injected with inverted MO. A comparable, albeit more subtle, phenotype was obtained by labeling of a subpopulation of the primary neurons by *islet1*. As in morphants, *islet1* neurons were slightly more numerous with what appeared to be higher levels of transcript than in the controls ([Fig. 2 D](#fig2){ref-type="fig"}). The increase of HuC-positive cells in the neural tube as evaluated by antibody to HuC protein is maintained at 24, 48, and 72 hpf ([Fig. 3, A and B](#fig3){ref-type="fig"}). The proportion of HuC+ cells in the neural tube was at all times higher in morphants as compared with wild-type embryos and, at 72 hpf, occupied even most of the ventricular zone known to consist of the proliferating cells ([Fig. 3, A and B](#fig3){ref-type="fig"}). However, low numbers of HuC-negative cells were at 72 hpf still present in the ventricular zone, suggesting that the proliferating compartment was not entirely depleted by loss of function d-Asb11.

![**Modulation of differentiation, proliferation, or apoptosis in the neural tube upon the knockdown of d-Asb11.** (A) HuC antibody labeling of postmitotic neurons in the spinal cord at 24, 48, and 72 hpf embryos of wild type (WT) and morphants (MO). (B) 3D reconstruction of a representative HuC-labeled 24 hpf morphant and wild-type embryo to calculate the proportion of postmitotic neurons (red, HuC-positive neurons; green, unlabeled cells; yellow, notochord). (C--E) Double immunofluorescence labeling of a mitotic cell with anti-PH3 antibody (green) and terminally differentiated neurons with anti-HuC antibody (red) at 24 (C) and 48 hpf (D) in morphants and wild-type neural tubes (anterior to the left) showing a transient, slight increase in proliferation at 24 hpf followed by a strong decrease in proliferation by 48 hpf and relative increase of HuC+ neurons (red). (E) Quantification of PH3+ mitotic cells. Error bars represent SEM. \*, P \< 0.05; \*\*, P \< 0.005. (F, left) Acridine orange staining at 24 hpf showing enhanced apoptosis in the neural tube of morphants (arrowhead) and few apoptotic cells in wild-type embryos (lateral view, rostral to the left). (right) TUNEL assay shows increased apoptosis (blue cells) throughout in the neural tube of 24 hpf morphants versus only Rohon-Beard apoptosis in the dorsal-most neural tube of the control embryo. Transverse sections through the neural tube are shown. Bars (A), 20 μm; (B--D) 100 μm; (F, left) 200 μm; (F, right) 20 μm.](jcb1740581f03){#fig3}

To quantify the proportion of postmitotic neurons relative to presumably proliferating unlabeled precursors that reside in the ventricular zone of the CNS, a 3D reconstruction of serial sections from a 24 hpf wild-type embryo and a representative 24 hpf morphant was made ([@bib41]). The measurements show that HuC+ cells contribute to 28% of the total volume of the neural tube in the wild-type embryo and 36% in the morphant, confirming that the proportion of postmitotic neurons is increased in the morphant embryo ([Fig. 3, A and B](#fig3){ref-type="fig"}). These data suggest that the targeted knockdown of d-Asb11 results in premature postmitotic neuronal commitment of a subpopulation of neural precursors.

Knockdown of d-Asb11 impairs cell division in the developing nervous system
---------------------------------------------------------------------------

At 24 hpf, the expanded *ngn1* compartment in the morphants could hold both terminally differentiated neurons as well as still-dividing *ngn1*+ precursors. To verify whether the HuC+ cells were indeed nondividing terminally differentiated neurons, we performed double fluorescent whole-mount antibody labeling with HuC and a mitotic marker anti--phosphohistone-3 (PH3) antibody. Examination of nine morphants and seven wild-type embryos revealed that there was no colocalization of the HuC+ and PH3+ signals (see Whole-mount immunolabeling). The data show that the knockdown of d-Asb11 resulted in a relative and premature increase of terminally differentiated nondividing neurons already at 24 hpf ([Fig. 3 C](#fig3){ref-type="fig"}). It is very well possible that a fraction of the supernumerary *ngn1*+ cells in the morphants was still proliferating and, therefore, was not expressing HuC. The comparison of numbers of mitotic PH3+ cells between morphants and controls at 24 hpf showed that in the morphants, there was a slight but significant (P \< 0.03) increase in proliferation that was most likely caused by ectopic proliferating *ngn1*+ neurons ([Fig. 3 E](#fig3){ref-type="fig"}). These data suggest that d-Asb11 functions to prevent neuronal commitment possibly by sustaining proliferation. The reduction of the definitive neuronal compartment may be the result of the depletion of neural progenitors through decline in proliferation. This is supported by a highly significant (P = 0.008) decrease in PH3+ mitotic cells at 48 hpf ([Fig. 3, D and E](#fig3){ref-type="fig"}).

Effects of d-Asb11 on compartment size through apoptosis
--------------------------------------------------------

Concurrent to the decrease in proliferation, the apoptosis of prematurely committed precursors could also contribute to a reduction in compartment size. To study this possibility, we analyzed whether the increase of HuC+ cells in the morphants was accompanied by apoptosis in the neural tube. We found slightly enhanced apoptosis at 24 hpf morphants using acridine orange as an indicator of apoptosis ([Fig. 3 F](#fig3){ref-type="fig"}). Analysis of apoptotic cells was extended using TUNEL assay ([Fig. 3 F](#fig3){ref-type="fig"}). Transversal sections of the neural tube of wild-type embryos showed apoptotic Rohon-Beard neurons, whereas throughout the entire neural tube of the morphants, there was an increase in apoptosis ([Fig. 3 F](#fig3){ref-type="fig"}). This suggests that cell survival of the prematurely committed neuronal precursors may be compromised as a consequence of d-Asb11 knockdown.

Effects of d-Asb11 knockdown on neuronal development are upstream of the SoxB1 HMG group of transcription factors
-----------------------------------------------------------------------------------------------------------------

Because d-Asb11 appears to function in preventing neuronal commitment of the progenitors, we studied whether knockdown of d-Asb11 altered the expression of neural progenitor genes *sox2* or *sox3* of the SoxB1 high mobility group (HMG) box transcription factors. The expression of *sox2* and *sox3* through evolution correlates directly with ectodermal cells that are competent to acquire neural fate and subsequently may correlate with the commitment of cells to a neuronal fate ([@bib36]; [@bib43]). The expression of *sox2* and *sox3* in the zebrafish developing CNS is found in the regions containing neural precursors as well as those containing neurons ([@bib35]). The situation is complex, as neither *sox2* nor *sox3* is uniformly expressed in all neural-competent cells of the neural plate. This is because there are other SoxB1 genes expressed in the developing CNS of zebrafish and because the kinetics of expression during the transition between the neural precursor and neuron has thus far not been elucidated.

Strikingly, the knockdown of d-Asb11 affected the expression of both *sox2* and *sox3*, albeit differently. At 20 hpf, *sox3* expression in the neural tube was reduced in 50% of the morphants ([Fig. 4 B](#fig4){ref-type="fig"}), suggesting that d-Asb11 may function to maintain specific levels of *sox3* transcripts that may be required for precursor cell maintenance. If this is the case, d-Asb11 does so, most likely, in conjunction with other factors because the expression of *sox3* was weaker but still present. This difference in the intensity of *sox3* expression between morphants and controls is already clear in whole-mount in situ hybridizations ([Fig. 4 B](#fig4){ref-type="fig"}). At 20 hpf in the neural tube of controls, *sox2* transcripts were cellularly condensed and appeared to be localized in specific compartments of the cell ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast, in 40% of the morphants, *sox2* transcripts were diffuse and appeared scattered evenly throughout the cell ([Fig. 4 A](#fig4){ref-type="fig"}). The data suggest that d-Asb11 may be required for subcellular condensation of *sox2* transcripts. We speculate that such condensed transcripts may be representative of a specific localization, and, in this form, *sox2* may be required for maintenance of the precursor cell fate. Such a mechanism of segregating and subcellularly localizing molecular determinants in precursor cells through, for instance, interactions with the cytoskeleton has extensively been studied in neuroblast development in *Drosophila melanogaster* ([@bib42]). These data show that the loss of d-Asb11 may mediate the reduction of a population of neural precursors through affecting neural competence factors of SoxB1 HMG group transcription factors.

![**Effect of d-Asb11 knockdown and misexpression on *Sox2* and *Sox3* expression in embryos.** (A and B) Altered mRNA expression of neural precursor genes *sox2* and *sox3* upon the knockdown of d-Asb11 in transversal sections of neural tubes and whole-mount in situ hybridizations (insets) showing at 20 hpf the lower expression of *sox3* in the morphants and diffuse as opposed to condensed (in the wild types) expression of *sox2* in the morphants. (C) Double whole-mount in situ hybridization for *sox2* and anti-MT antibody labeling showing that MT--d-Asb11 is present in the cells ectopically expressing *sox2* (four-somite stage embryo; anterior to the left). Bars, 100 μm.](jcb1740581f04){#fig4}

Forced expression of d-Asb11 maintains progenitor expansion and impairs neurogenesis
------------------------------------------------------------------------------------

Confirmation for d-Asb11 function in vivo and the possibility of its involvement in the transition of neural precursor to neuron was obtained in experiments in which we investigated whether the misexpression of *d-asb11* mRNA would interfere with primary neurogenesis by evaluating *islet1* expression, a marker for primary neurons, as well as the expression of neuronal markers *ngn1* and *huC* ([Fig. 5, A and B](#fig5){ref-type="fig"}). Indeed, in 70% of the embryos, *islet1* expression was affected ([Fig. 5 A](#fig5){ref-type="fig"}). Most prominent was a reduction or total absence of *islet1* expression in the lateral sensory Rohon-Beard neurons. Occasionally, defects in the ventromedial motor neurons or the cranial ganglia were observed. Immunolabeling demonstrated that MT--d-Asb11 was present in the domains that did not contain *islet1* labeling. Comparable results were obtained with *ngn1* and *huC* ([Fig. 5 B](#fig5){ref-type="fig"}).

![**Misexpression of d-Asb11 causes altered expression of different markers.** (A) Quantitative analysis of defects in *islet1* expression upon the misexpression of *MT--d-asb11*, *MT--d-asb11--ΔC*, or *MT--d-asb11--ΔSOCS*. Data are pooled from four independent experiments, and the SEM (error bars) is shown. (right images) Repression of *islet1* expression by the misexpression of *d-asb11* mRNA. (top left) Wild-type (WT) *islet1*. (top right) Absence of Rohon-Beard neurons at the injected side. (middle) Absence of the primary motor neurons and displacement of the cranial ganglia. (bottom) Immunolabeling of MT--d-Asb11 in *islet1*-labeled injected embryos. Immunolabeling of *MT--d-asb11*--injected embryos with the anti-myc antibody (9E10) demonstrates that one half is positive for MT--d-Asb11 translation and corresponds to defects in *islet1* labeling. (far right) Misexpression of *d-asb11--ΔC or d-asb11--ΔSOCS* mRNA induces significantly fewer defects in *islet1* expression. (B) Loss and abnormalities in *ngn1*- and *huC*-labeled neurons upon the misexpression of *MT--d-asb11* mRNA. (C) Misexpression of *MT--d-asb11* mRNA induces ectopic expression of *her1* (middle) or a subtle defect in *her1* expression (bottom) as compared with wild-type *her1* expression (top). (far right) Patterning of the neural plate in wild-type embryos and embryos misexpressing *MT--d-asb11* mRNA as revealed by the mid/hindbrain marker *her5*. Misexpression of *d-asb11--ΔC or d-asb11--ΔSOCS* induces significantly fewer defects. (D) A combination of mid/hindbrain marker *pax2.1* and *krox20* marker for rhombomeres 3 and 5 reveals the loss of expression in embryos overexpressing *d-asb11* mRNA. (E, left) GCNF is in the wild-type embryos expressed in the entire neural plate (middle), whereas GCNF expression is absent in the areas where MT--d-Asb11 is misexpressed (right). Anterior to the top in A--C and to the left in D and E. Asterisks mark the injected side of the embryo (three- to five-somite stage embryos). mRNA was injected into one of the two blastomeres. Bars, 100 μm.](jcb1740581f05){#fig5}

To verify whether aberrant patterning of the neural plate could underlie abnormalities in primary neurogenesis, we evaluated the expression of regional neural plate markers *her5*, *pax2.1*, and *krox20* upon the misexpression of *d-asb11.* Next to the wild-type expression pattern, we observed a reduction of marker gene expression in embryos ([Fig. 5, C and D](#fig5){ref-type="fig"}). Most interestingly, we observed embryos in which marker expression was indicative of a split or otherwise deformed neural plate ([Fig. 5, C and D](#fig5){ref-type="fig"}), suggesting that in regions misexpressing MT--d-Asb11, neural plate formation was disrupted. To investigate whether the loss of *islet1*-positive neurons and/or abnormalities in *her5, pax2.1*, and *krox20* expression were secondary to neural plate defects, we studied the effect of *d-asb11* misexpression on the expression of germ cell nuclear factor (GCNF) as a neural plate marker ([@bib8]; [@bib5]). The regional overexpression of MT--d-Asb11 as detected by anti-MT antibody labeling at the three-somite stage overlapped with the region of the neural plate where GCNF was absent ([Fig. 5 E](#fig5){ref-type="fig"}). This suggests that d-Asb11 negatively interfered with the establishment of the neural plate and that the absence of *islet1*-, *ngn1*-, and *huC*-labeled neurons and aberrant *her5*, *pax2.1*, and *krox20* expression are the consequence of this event. To exclude the possibility that the misexpression of *d-asb11* mediates nonspecific repression of gene expression, we evaluated several markers upon the misexpression of *d-asb11*. Interestingly, the expression of the Notch target gene *her1* was ectopically expanded in embryos misexpressing *d-asb11* ([Fig. 5 C](#fig5){ref-type="fig"}), whereas the expression of *ptc1* was unaffected (not depicted), ruling out the possibility that *d-asb11* is a general transcriptional repressor.

Effects of d-Asb11 misexpression on neuronal development are upstream of the SoxB1 HMG group of transcription factors
---------------------------------------------------------------------------------------------------------------------

The aforementioned experiments suggest that d-Asb11 may, when misexpressed, function to block neuralization through forced maintenance of the precursor cell fate. In support of this notion, the phenotype of d-Asb11 morphants is characterized by altered expression of neural competence factors *sox2* and *sox3*. To establish whether d-Asb11 misexpression may mediate its effects in preventing neuronal differentiation through the induction of *sox2* expression, we misexpressed *MT--d-asb11* mRNA. As a result, we sporadically observed scarce ectopic *sox2*-positive (sox2+) cells (unpublished data). In an attempt to increase the inefficiency of *MT--d-asb11* mRNA misexpression, we microinjected *MT--d-Aasb11* DNA in embryos. Although the frequency of ectopic induction of *sox2*+ cells (∼5%) remained low, the ectopically induced cells were more numerous. The ectopic expression of *sox2* coincided with MT--d-Asb11 protein expression ([Fig. 4 C](#fig4){ref-type="fig"}). These data show that when misexpressed, d-Asb11 is capable of inducing the neural precursor gene *sox2. sox2* is expressed in neural precursors as well as in neurons. As d-Asb11 misexpression inhibited neurogenesis ([Fig. 5](#fig5){ref-type="fig"}), we propose that through its positive regulation of the *sox2* gene, d-Asb11 may maintain neural-competent cells in their precursor state. The low frequency of this ectopic induction suggests a requirement for other limiting factors in order for d-Asb11 to induce *sox2.* Alternatively, potential negative regulators of *sox2* would have to be excluded from cells to ectopically express *sox2.*

The SOCS box is required for defects upon the misexpression of d-Asb11
----------------------------------------------------------------------

We obtained functional insight into the molecular mechanism by which d-Asb11 acts from experiments in which we investigated the action of mutated versions of *d-asb11* with a specific deletion of the SOCS box (*d-asb11--ΔSOCS*) or of the entire C-terminal part after the last ankyrin repeat (*d-asb11--ΔC*) using as a read-out their effects on *islet1* neurons or on neural plate patterning as revealed by *her5*. Importantly, both mutant molecules resulted in a marked decrease of an altered expression pattern of *islet1* when injected into zebrafish embryos ([Fig. 5 A](#fig5){ref-type="fig"}). As we have already shown, the expression of *her5* at early somitogenesis was clearly affected by the misexpression of *d-asb11*, as in ∼50% of the embryos, one half of the V-shaped expression domain at the mid/hindbrain boundary was shifted laterally or was diminished ([Fig. 5 C](#fig5){ref-type="fig"}). Likewise, when *d-asb11--ΔC* or *d-asb11--ΔSOCS* mRNA was microinjected, the wild-type expression pattern of *her5* was maintained in a high percentage of embryos ([Fig. 5 C](#fig5){ref-type="fig"}). Thus, the SOCS box of d-Asb11 is required for its biological effects.

The SOCS box of d-Asb11 is a component of the ubiquitin ligase complex
----------------------------------------------------------------------

As mentioned in the second paragraph of Results, SOCS boxes frequently act in ubiquitin ligase complexes, and because the SOCS box in d-Asb11 appears to play an important role during embryogenesis, we determined whether the SOCS box in d-Asb11 is also able to function as an ubiquitin ligase. Indeed, the overexpression of d-Asb11 either in zebrafish embryos or in HeLa cells led to the ubiquitination of a variety of cellular proteins in a SOCS box--dependent fashion ([Fig. 6, A and B](#fig6){ref-type="fig"}), demonstrating that d-Asb11 is capable of functionally participating in a ubiquitin ligase complex and again showing that d-Asb11 is a member of the ASB family ([@bib23]; [@bib10]; [@bib21]). Importantly, cells transfected with the control expression vector or with SOCS box--deficient d-Asb11 were incapable of ubiquitination ([Fig. 6, A and B](#fig6){ref-type="fig"}). Thus, d-Asb11 can act as an ubiquitin ligase in a SOCS box--dependent fashion. Ankyrin repeats are important mediators of protein--protein interaction, and, thus, we reasoned that if d-Asb11 has the capacity to act as an ubiquitin ligase, it is most likely acting on ankyrin repeat--containing proteins. Indeed, we observed that upon coexpression in HeLa cells, d-Asb11 coimmunoprecipitates with various ankyrin repeat--containing proteins, including I-κBα and Notch, but not recombining binding protein-Jκ, which does not contain ankyrin repeats ([Fig. 6, C--E](#fig6){ref-type="fig"}).

![**d-Asb11 acts as an ubiquitin ligase in vitro.** (A) HeLa cells were transfected with either MT alone, MT--d-Asb11, or MT--d-Asb11--ΔC in combination with HA-ubiquitin. Before stimulation, 10 μM of the proteasome inhibitor MG-132 was added, and cells were stimulated for 60 min with 10 ng/ml IL-1β. Equal amounts of protein were immunoprecipitated with anti--IκB-α antibody and subsequently analyzed for the presence of ubiquitinated proteins by immunoblotting with ubiquitin antibody. (B) HeLa cells were transfected with MT-Notch1a intracellular domain and either HA--d-Asb11 or HA--d-Asb11--ΔC in combination with HA-ubiquitin. Before immunoprecipitation, 10 μM of the proteasome inhibitor MG-132 was added, and cells were further processed after 60 min. Equal amounts of protein were immunoprecipitated with anti-MT antibody and subsequently analyzed for the presence of ubiquitinated proteins by immunoblotting with ubiquitin antibody. (C) d-Asb11 can bind to Notch intracellular domain in a SOCS box--independent manner. (D) HEK293 cells were transfected with HA--d-Asb11 and/or IκB-α (middle and bottom). Equal amounts of cell lysates were immunoprecipitated with the anti-HA antibody and analyzed for IκB-α expression. IκB-α was detected in the precipitate of HA-tagged proteins (top). (E) Recombining binding protein-Jκ is not able to bind to d-Asb11.](jcb1740581f06){#fig6}

d-Asb11 overexpression prevents terminal neuronal differention in vitro
-----------------------------------------------------------------------

The loss and gain of function experiments in zebrafish embryos suggest that d-Asb11 acts as a molecule that supports the maintenance of neuronal precursors possibly by safeguarding the proper identity and expansion of the precursor stem cell compartment. This notion was further tested using a specific neuronal progenitor cell line (PC12) and a pluripotent embryonic carcinoma cell line (Nt2-D1; [@bib15]; [@bib2]). Experiments on PC12 cells were performed using an NGF-induced in vitro differentiation of PC12 pheochromocytoma cells according to the standard protocols ([@bib15]; [@bib40]). Upon NGF stimulation, the cells transfected with control DNA showed a decrease in proliferation, which was determined by MTT (3-\[4,5-dimethyl-2-thiazolyl\]-2,5-diphenyl-2H-tetrazolium bromide) activity, and the expression levels of proliferating cell nuclear antigen (PCNA) and neurites were formed ([Fig. 7, A and B](#fig7){ref-type="fig"}). Strikingly, when d-Asb11 was overexpressed in PC12 cells, the proliferation was sustained, and the amount of neurites was significantly reduced ([Fig. 7, A and B](#fig7){ref-type="fig"}). Importantly, PC12 cells overexpressing d-Asb11 appear to continue proliferating upon NGF-induced differentiation, as they form overlaying colonies in contrast to control cells that remained in a monolayer ([Fig. 7 C](#fig7){ref-type="fig"}). The lack of NGF-induced neurite extension in d-Asb11--expressing PC12 cells may be caused by the incapacity of these cells to initiate neuronal differentiation but, alternatively, may reflect a block further down in the execution of the neuronal differentiation program. To distinguish between these possibilities, we investigated the expression of growth cone--associated protein 43 (GAP-43), a marker already expressed in proliferating neuroblasts, and the neurofilament, a marker of terminally differentiated neurons ([@bib24]; [@bib30]; [@bib37]). As expected from the neurite extension experiments, transfection of *MT--d-asb11* into PC12 cells inhibited neurofilament expression as assayed either by immunoblotting ([Fig. 7 D](#fig7){ref-type="fig"}) or immunofluorescence ([Fig. 7 C](#fig7){ref-type="fig"}). Importantly, however, d-Asb11 enhanced the NGF-dependent expression of GAP-43 ([Fig. 7 D](#fig7){ref-type="fig"}).

![**Effect of d-Asb11 on differentiation in PC12 or Nt2-D1 cells.** (A) Proliferation of PC12 cells upon NGF stimulation. Relative mitochondrial activity was measured (MTT assay), and PCNA expression levels were determined. The experiments were performed in duplicate, and the values shown are the means and SEM (error bars) of 11 different samples. (B) Neurite length was measured in at least 10 different fields of cells for each condition. \*\*, P \< 0.01. (C) Fluorescent double labeling of PC12 cells transfected with MT or MT--d-Asb11. d-Asb11 inhibited neurofilament (NF) expression and allowed continued cell proliferation as compared with MT-transfected cells. (D) The protein expression profile of GAP-43 and neurofilament of whole cell lysates in PC12 cells after NGF stimulation. (E) Expression of neurofilament, PH3 (Ser10), and actin in Nt2-D1 cells after RA addition. Bars, 200 μm.](jcb1740581f07){#fig7}

To examine the effects that d-Asb11 may have upon the differentiation of uncommitted pluripotent embryonic carcinoma cells ([@bib2], [@bib3]), we chose Nt2-D1 cells that differentiate primarily into neurons upon RA treatment ([@bib1]). When d-Asb11 was overexpressed in the Nt2-D1 cell line, it inhibited the RA-induced differentiation into neurons, as shown by diminished neurofilament expression ([Fig. 7 E](#fig7){ref-type="fig"}). Importantly, as in PC12 cells, these cells were still mitotically active, as shown by increased PH3 expression, suggesting that these pluripotent cells are also blocked in a phase before terminal neuronal differentiation. Thus, the overexpression of d-Asb11 in both PC12 and Nt2-D1 cells enhances proliferation of the committed neural precursor in spite of differentiation stimuli. These in vitro data are therefore consistent with the inhibition of neurogenesis upon the misexpression of d-Asb11 in the embryo.

Discussion
==========

We have shown that in the developing zebrafish embryo, *d-asb11* is expressed in the neural plate margins and is complementary to and abutting the proneuronal zone, as defined by *deltaA* staining. Before early somitogenesis, *d-asb11* is ubiquitously expressed in the pluripotent cells of the blastoderm ([Fig. 1 B](#fig1){ref-type="fig"}). Progressive restriction of *d-asb11* to the lateral regions of the neural plate as well as its transient expression at that location suggests that d-Asb11 may indeed support the stem cell fate.

Upon the knockdown or misexpression of *d-asb11*, the size of the terminally differentiated neuronal compartment increases or decreases, respectively, suggesting that d-Asb11 is involved in regulation of the number of neurons that eventually arise. The relatively subtle minor initial increase in neurogenesis upon d-Asb11 knockdown, as not all dorsal or lateral precursors are induced to differentiate, may implicate redundancy with other ASB family members from this group (Fig. S1). Alternatively, the strictly localized and transient expression of *d-asb11* could affect only a small subset of neural precursors, thereby resulting in this subtle phenotype.

We propose that during zebrafish development, d-Asb11 maintains the undifferentiated neural-competent state of a subpopulation of cells in the neural plate until its expression is down-regulated by subsequent differentiation signals (e.g., RA; [@bib38]). Because *d-asb11* is only transiently expressed from 4 hpf until the 12-somite stage, upon its disappearance, cells devoid of d-Asb11 would become sensitive to secondary inductive signals and would be able to pursue the appropriate neuronal cell fate. Interestingly, the timing of extinguishing *d-asb11* mRNA expression at ∼12 somites roughly corresponds with the final round of DNA synthesis occurring between 9 and 16 hpf in motor neurons ([@bib32]). As first secondary neurons are born ∼6 h after the first primary neurons, it may be that d-Asb11 functions to separate waves of primary and secondary neurogenesis by maintaining a pool of precursors to respond to inductive signals operating later in development.

The loss of function of d-Asb11 causes premature neuronal commitment that is reflected in ectopic *ngn1* expression and followed by a relative increase of HuC+ terminally differentiated neurons. In parallel, a progressive loss of ventricular zone cells occurs, resulting in reduction of the definitive neuronal compartment. Importantly, d-Asb11 may mediate its effects through control of SoxB1 neural precursor genes, as the knockdown results in a reduced and aberrant expression of *sox3* and *sox2,* respectively. Concurrently, when misexpressed, d-Asb11 prevents neuronal differentiation possibly through the induction of *sox2* or yet another SoxB1-type factor. Both gain of function and loss of function of d-Asb11 phenotypes in zebrafish are in agreement with experiments in the chick in which the overexpression of Sox2 and/or Sox3 also inhibits neuronal differentiation of neural progenitors, which then maintain their undifferentiated state and capacity to proliferate. In contrast, dominant-negative Sox2 and/or Sox3 in neural progenitors results in premature exit from the cell cycle, and neuronal differentiation ensues ([@bib9]; [@bib14]). Our data are consistent with a model in which d-Asb11 supports the maintenance of a proliferative subpopulation of neural precursors. We further propose that d-Asb11 may control this process through SoxB1 neural precursor genes.

Consistent with such a model, it has been proposed that SoxB1 genes play a role in maintaining neural progenitors in the cell cycle and regulate the timing of their exit from the cell cycle. The findings that the inhibition of SOX2 function in chick neural progenitors ([@bib14]) and rat oligodendrocyte precursor cells ([@bib28]) leads to their premature exit from mitosis support this hypothesis and are in agreement with loss of function d-Asb11, as d-Asb11 knockdown similarly leads to the reduction of mitotic cell numbers after 24 hpf.

The role of d-Asb11 in maintaining the proliferative state of precursors was also illustrated in in vitro differentiation models. When d-Asb11 is overexpressed in a neural-committed progenitor or a pluripotent cell line, these cells are unable to execute the terminal neuronal differentiation program, as shown by the inhibition of neurofilament expression upon exposure to stimuli that cause neuronal differentiation. Consistently, the proliferation was not inhibited in these cells as it was in the controls, indicating that d-Asb11 is able to block terminal neuronal differentiation and allow cells to proliferate.

Because PC12 is already committed to neural crest fate, the overexpression of d-Asb11 cannot prevent the PC12 cell in activating its neuronal differentiation program (enhanced GAP-43 expression in d-Asb11--transfected cells), but it can hold these cells in a state of proliferating neuroblast precursors. Consistent with the proposed role of d-Asb11 in the maintenance of neural precursors, GAP-43 is reported to be expressed in proliferating neuroblasts, and its function has been implicated in the cell cycle, differentiation, and, eventually, also cell survival ([@bib24]; [@bib30]; [@bib37]). Importantly, PC12 cells overexpressing d-Asb11 appear to have a block in further execution of the neural differentiation program (as they have diminished neurites and lower neurofilament expression). Our data suggest that d-Asb11 acts to maintain cells in the neuroblast state independently of their primary status, being either pluripotent (Nt2-D1) or neural progenitor (PC12) cells.

Consistently, the misexpression of XSox3 with XBF1 promotes the proliferation of neuroectodermal cells in *Xenopus laevis* embryos ([@bib18]). We speculate that the misexpression of d-Asb11 in zebrafish embryos perhaps through the induction of *sox2* or another SoxB1-type factor may similarly affect the fate of zebrafish neuroectodermal cells, thereby abolishing neuronal differentiation. The in vitro data on Nt2-D1 and PC12 cells, a pluripotent and a neuronal-committed cell line, respectively, also suggest that d-Asb11 functions by maintaining the proliferative state of the neural precursors, thereby making them refractory to differentiation signals perhaps through regulating SoxB genes.

Our findings show that d-Asb11 functions as a regulator of progenitor cell maintenance. More specifically, it keeps progenitors in a less differentiated, more proliferative state. Although little is known about the functions of ASB proteins, the fact that ASB5 (which is highly homologous to d-Asb11) has a role in arteriogenesis strengthens the notion that this class of ASB proteins may have a role in cell fate decisions ([@bib7]).

Interestingly, a possible role for d-Asb11 in the development of the brain has recently indirectly been uncovered by the experiments performed by [@bib34]. They compared the genetic mutations between the human and chimpanzee genome, looking for genes with an unusually higher number of functional nucleotide changes between the two species, which would suggest a possible important role for such genes in the definition of being a chimpanzee or a human. Most of these genes were involved in the immune and reproductive systems, but ASB11 was among the highly altered genes between the human and chimpanzee genome despite its generally very high level of conservation in the chordate phylum. It is of course tempting to suggest that the obvious size differences between human and chimpanzee brains are also a result of altered ASB11 function.

Materials and methods
=====================

Fish and embryos
----------------

Zebrafish were kept at 27.5°C. Embryos were obtained by natural matings, cultured in embryo medium, and staged according to [@bib27]; [@bib44]).

Cell cultures
-------------

HEK293, HeLa, Nt2-D1, and PC12 cells were maintained in DME containing 10% FCS. The culture medium was supplemented with 5 mM glutamine and antibiotics/antimitotics. Cells were incubated in a 5% CO~2~ humidified incubator at 37°C.

Plasmid construction
--------------------

pCS2+MT (MT; myc-tagged expression vector), pCS2+MT--d-Asb11 (MT--d-Asb11), pCS2+MT--d-Asb11--ΔC (MT--d-Asb11--ΔC), and pMT2SM-HA--d-Asb11 (HA-tagged expression vector; HA--d-Asb11) were constructed as follows: an expression vector containing *d-asb11*, the coding region, was cloned into the BamHI--XhoI sites of the pCS2+ expression vector. To obtain a myc-tagged version of *d-asb11* (*MT--d-asb11*), the coding region was cloned into the NcoI--XhoI sites of pCS2+MT. An *MT--d-asb11--ΔC* construct encoding a C-terminal deletion (aa 229--293) was generated by digesting *MT--d-asb11* with XbaI. All expression constructs were checked for errors by sequencing. For HA-tagged d-asb11 (HA--d-asb11), d-asb11--ΔC (HA--d-asb11--ΔC), and d-asb11--ΔSOCS (HA--d-asb11--ΔSOCS), the coding region was cloned into the XhoI--EcoRI sites of pMT2SM-HA, and the expression constructs were subsequently verified by sequencing. To obtain a construct for RNA synthesis of *asb-a* to control mRNA injections of MT--d-asb11 mRNA, the 1.6-kb *asb-a* cDNA was cloned into the BglII and XhoI sites of pT7TS+. A partial cDNA fragment of *asb-a* in pBluescript was used as a template to generate a riboprobe for in situ hybridizations.

mRNA synthesis, mRNA and DNA microinjections, and rescue of d-Asb11 knockdown with the misexpression of MT--d-asb11 mRNA
------------------------------------------------------------------------------------------------------------------------

Capped mRNAs were synthesized using the mMESSAGE mMACHINE kit (Ambion). In rescue experiments of d-Asb11, knockdown MT--d-asb11 mRNA at concentrations ranging from 2.5 to 50 pg was injected in 1 nl at the yolk/blastoderm interface in the one-cell stage upon microinjection with d-asb11 MO in one-cell stage embryos such that MO-injected only embryos were the control for embryos first injected with the MO and then with d-asb11 mRNA. A chi-squared test was performed to determine the statistical differences in percent morphology in MO and potentially rescued MO-injected embryos The rescue could be performed because the MO-1 sequence was complementary to the 5′ untranslated sequences not incorporating the ATG translation start site. In the MT--d-asb11 construct, myc was fused directly to the ATG, thus lacking the MO-1 target sequences.

To misexpress wild-type or mutant versions of *d-asb11* mRNA, zebrafish embryos were injected at the two-cell stage in one of the two blastomeres (300 pg mRNA), resulting in defects in the injected half of the embryo. To misexpress MT--d-asb11 DNA, 10 pg was microinjected into zygotes.

In situ hybridization
---------------------

Whole-mount in situ hybridizations were performed according to [@bib22] and for sox2 were performed according to [@bib12]. Double label whole-mount in situ hybridization was performed according to [@bib20]. For histological analysis, upon in situ hybridization, embryos were overstained for 48 h, subsequently fixed for 1 h in 4% PFA in phosphate buffer, dehydrated, embedded in plastic, and sectioned. *deltaA* and *huC* probes were provided by B. Appel (Vanderbilt University, Nashville, TN). Probes for *her1* and *her5* were provided by L. Bally-Cuif (Institute of Developmental Genetics, Neuherberg, Germany). U. Strahle (Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe, Karlsruhe, Germany) provided the probes for *ngn1* and *islet1*. V. Cunliffe (Centre for Developmental Genetics, University of Sheffield, Sheffield, United Kingdom) and S. Wilson (University College London, London, United Kingdom) provided the *sox2* and *sox3* probes, respectively.

Acridine orange staining
------------------------

Acridine orange staining was performed as described previously ([@bib13]) with modification of the acridine orange (Sigma-Aldrich) solution (0.078 μg/ml in embryo medium).

TUNEL assay
-----------

TUNEL assay was performed as described previously by [@bib11] with modification of the staining reaction. Antidigoxigenin antibody was preabsorbed in blocking buffer (1% DMSO and 2% BSA in PBS) for 1 h at 4°C. Embryos were incubated overnight in blocking buffer with 1:2,000 antidigoxigenin antibody at 4°C, washed eight times with PBS, and stained according to the method used for in situ hybridization.

cDNA library screen
-------------------

A random primed λZAP neurula cDNA library prepared from 3 to 15 hpf embryos was used to screen 1.5 × 10^6^ phages to obtain a full-length clone. The probe was labeled to high specific activity with α-\[^32^P\]dCTP (GE Healthcare) using a Rediprime labeling kit (GE Healthcare). After in vivo excision, the longest positive clone was subcloned and sequenced.

MOs
---

Antisense MOs (Gene Tools, LLC) were designed to complement the 5′ untranslated sequences of *d-asb11* (d-asb11--MO-1; 5′-AGAAACCTCGCAGACAGCAACGGTC-3′) or sequences upstream and including the ATG start site (d-asb11--MO-2; 5′-CCATCTCTAAACTAAAACACAGCCA-3′), and, as a control, an inverted MO (d-asb11--MO; 5′-CTGGCAACGACAGACGCTCCAAGA-3′) was used. Approximately 9 ng/1 nl was injected into one-cell stage embryos, whereas as a control, we injected ∼15 ng/1 nl of inverted MO.

Whole-mount immunolabeling
--------------------------

For whole-mount immunohistochemistry, fixed embryos were rinsed in PBS and incubated in blocking solution for 1 h (PBS + 0.1% Tween 20 containing 1% BSA and 2% normal lamb serum). The primary antibody (anti-HuC; Sigma-Aldrich) was added, and embryos were incubated overnight at 4°C. After washing in PBS + 0.1% Tween 20, embryos were incubated overnight at 4°C in goat anti--mouse peroxidase-conjugated secondary antibody. After extensive washing, embryos were incubated in 0.5 mg/ml DAB and reacted in 0.003% H~2~O~2~. For the double fluorescent whole-mount antibody staining with anti-HuC and anti-PH3 antibody (Upstate Biotechnology), fixed embryos were permeabilized for 4 min in 2.5 mg/ml ice-cold trypsin in PBT (PBS + 0.1% BSA + 0.1% Tween 20; Worthington Biochemical Corp.) on ice, subsequently washed three times for 5 min each in PBT, and incubated for at least 1 h in blocking buffer (2% lamb serum, 0.1% BSA, 0.1% DMSO, and 1% Triton X-100 in PBS). To detect HuC and PH3, respectively, secondary antibodies were Cy3 and Cy5 conjugated. Immunofluorescently labeled embryos were analyzed in 100% glycerol using confocal laser scanning microscopy at ambient temperature.

Analysis of confocal images
---------------------------

Potential cellular colocalization of HuC and PH3 signal in double immunofluorescence experiments was analyzed using Volocity 3 software (Improvision). To this end, all 50 optical z slices per embryo were scored (in total seven wild type and nine morphants at 24 hpf and seven wild types and eight morphants at 48 hpf).

To determine numbers of PH3-positive cells, they were scored manually on the cumulative z series for each embryo (for *n* see Results). The cells were counted at 30,000× magnification in a standardized square of 7-cm length and depth covering the extent of the neural tube defined by HuC antibody labeling. Comparable regions were chosen in morphants and wild types with reference to the yolk-tube extension.

3D reconstruction and calculation
---------------------------------

Volumes were calculated from a 3D reconstruction from 7-μm serial sections with an acquisition station ([@bib41]). This resulted in 123 section images for the control and 149 section images for the treated fish. The notochord and otic vesicle were included to have a frame of reference.

Microscopy and image quantification
-----------------------------------

Pictures were obtained using a microscope (Axioplan; Carl Zeiss MicroImaging, Inc.) with a 10× NA 0.30 plan Neofluar or a 40× NA 0.65 Achroplan lens on a Leica microscope (TCS NT). Images were digitized with a camera (DFC480; Leica) and processed with the IM500 Image Manager (Leica). A stereomicroscope (MZ FLIII; Leica) with a camera (DC 300F; Leica) was used for [Figs. 2 A](#fig2){ref-type="fig"} and [7 B](#fig7){ref-type="fig"}. Digital pictures of transversal sections of *ngn1* in situ hybridizations were then quantified with Image Analysis software (EFM Software) by calculating the total signal intensity. The pictures of sections were corrected from embryo size by dividing the amount of staining by the size of the embryo surface.

Digital pictures of whole-mount in situ hybridizations were obtained using a digital camera (DXM1200; Nikon). Some in situ images were used to determine the size of the stained compartments by counting the amount of positive pixels on the embryo and dividing this by the total size of the whole embryo. This number represents the relative size of positive cells in the whole embryo. All images were only adjusted for brightness, contrast, or color balance (autoequalize option).

MTT assay
---------

PC12 cells were transfected with MT alone or MT--d-Asb11 plus neomycin resistance plasmid (see supplemental material for plasmid construction). After 5 d, polyclonal neomycin-resistant PC12 cells were reseeded in 96-well plates and stimulated with 100 ng/ml NGF-2.5S (Invitrogen). After 3 or 6 d, 0.1 mg MTT (M5655; Sigma-Aldrich) was added to the medium. The cells were lysed by the addition of 50 μl MTT lysis buffer (20% SDS and 10% dimethylformamide) to the medium, and absorbance was measured at 570 nm. The results are the mean and standard error of 11 independent cultures obtained in two different experiments.

Measurement of the neurite length
---------------------------------

The mean neurite length in [Fig. 7 B](#fig7){ref-type="fig"} was measured by blinded counting of the total amount of neurites divided by the amount of counted cells using the Image Analysis software package (EFM Software).

Western blotting and immunofluorescence
---------------------------------------

PC12 cells were transfected with MT alone or MT--d-Asb11 plus a neomycin resistance plasmid. After 5 d, the polyclonal neomycin-resistant PC12 cells were reseeded in six-well plates for neurofilament and GAP-43 expression and on glass coverslips for immunofluorescence. Cells were subsequently stimulated with 100 ng/ml NGF-2.5S (Invitrogen). After stimulation, the cells were lysed in cell lysis buffer (Cell Signaling) supplemented with phosphatase and protease inhibitors or fixed in 4% PFA for 15 min and kept in PBS at 4°C.

Nt2-D1 cells were seeded in a 24-well plate 1 d before transfection using the MATra and IBAFect (IBA GmbH) transfection technique according to the standard supplier\'s protocol. After 24 h, the medium was refreshed and 10^−6^ M RA was added, and, after 48 h, the cells were lysed (Cell Signaling) and supplemented with phosphatase and protease inhibitors.

After cell lysis, the samples were loaded on SDS-polyacrylamide gels. The material was transferred to Immobilon (Millipore) by wet blotting in transfer buffer (50 mM Tris, pH 8.0, 40 mM glycine, 0.0375% SDS, and 20% methanol), and the blots were incubated for 1 h in blocking buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.05% Tween 20, and 5% nonfat milk). Blots were incubated overnight at 4°C in TBS-T (50 mM Tris, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 10% blocking buffer and 1:1,000 PCNA (Sigma-Aldrich), GAP-43 (Sigma-Aldrich), neurofilament (for PC12; 2H3; Developmental Studies Hybridoma Bank), neurofilament-M (for Nt2-D1; Cell Signaling), or β-actin (SC-1615; Santa Cruz Biotechnology, Inc.). The neurofilament antibody 2H3 was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences at the University of Iowa. The blots were washed in TBS-T. After incubation with the appropriate secondary antibody and extensive washing in TBS-T, the blots were developed by ECL.

After fixation, the cells were treated with PBS + 0.1% Triton X-100 for 5 min and subsequently blocked with PBS containing 5% normal goat serum. After blocking, the cells were incubated with 1:100 MT antibody (Cell Signaling) in PBS + 3% BSA and afterward incubated with 1:5,000 anti--rabbit Cy3. After the first staining, the cells were stained for neurofilament (2H3; Developmental Studies Hybridoma Bank) identical to the MT staining but with anti--mouse Cy5 as a secondary antibody. The cells were washed three times in PBS between every step. After staining, the glass coverslips were mounted in moviol. Immunofluorescently labeled cells were analyzed using confocal laser scanning microscopy at ambient temperature.

Rabbit immunization and serum preparation
-----------------------------------------

GST-tagged d-Asb11 was purified from *Escherichia coli* BL21 bacteria using glutathione--Sepharose beads. Rabbits were immunized with GST-tagged d-Asb11. Subsequently, the serum containing the polyclonal antibody directed against d-Asb11 was used in immunoblotting analysis.

Zebrafish cell lysates for immunoblotting
-----------------------------------------

Embryos were lysed in cell lysis buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 1.5 mM MgCl~2~, 1 mM EGTA, 10% glycerol, and 1% Triton X-100) at 4°C (7.5--12.5 μl/embryo). Loading buffer was added to the cell lysis buffer, and samples were boiled for 3 min. A total equivalent of five embryos was loaded per lane.

Online supplemental material
----------------------------

Supplemental material provides information about the identification of d-Asb11 and testing of d-asb11 morphants. Fig. S1 presents the characterization of d-Asb11 and the Asb subfamily of proteins. Fig. S2 shows the generation of a d-Asb11 antibody and validation of d-Asb11 expression during embryogenesis. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200601081/DC1>.
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